Ekosi Health Partners with Cerebra to Evaluate Effectiveness of Clinical Cannabinoid Therapy on Sleep Quality
Gimli, Manitoba, Nov. 08, 2022 (GLOBE NEWSWIRE) -- Ekosi Health , a Canadian-based and Indigenous-owned healthcare provider specializing in clinical cannabinoid therapy, announces its partnership with Cerebra , a leading sleep technology company, as the partners run an Observational Study that will assess the effectiveness of cannabinoid therapy on sleep quality.
- Gimli, Manitoba, Nov. 08, 2022 (GLOBE NEWSWIRE) -- Ekosi Health , a Canadian-based and Indigenous-owned healthcare provider specializing in clinical cannabinoid therapy, announces its partnership with Cerebra , a leading sleep technology company, as the partners run an Observational Study that will assess the effectiveness of cannabinoid therapy on sleep quality.
- With over 27,000 patient interactions, Ekosi Health has seen success in improving conditions ranging from chronic pain to substance misuse.
- Post conclusion of the Observational Study, Ekosi Health and Cerebra expect to extend the partnership to produce further valuable insights into cannabinoid therapy and sleep research.
- As a leader in sleep diagnostic technology, our innovative Cerebra Sleep System provides sleep researchers and clinicians with accurate, self-applied, in-home diagnostics.